Even more, the Neurotensin (NTS) rs1800832 variant predisposes to cirrhosis and HCC in NAFLD patients likely by affecting NTS protein activity [221]. This evidence concerns the gene NTS and metabolic dysfunction-associated steatotic liver disease.